BCRX Quote, Trading Chart, BioCryst Pharmaceuticals Inc.
home / stock / bcrx / bcrx quote
$11.37 Last:
1.97% Change Percent:
$11.255 Open:
$11.37 Previous Close:
$11.56 High:
$11.06 Low:
1,031,677 Volume:
03/08/2021 10:35:13 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-08 | 11.255 | 11.37 | 11.56 | 11.06 | 1,031,677 |
| 2021-03-05 | 11.08 | 11.15 | 11.19 | 9.6901 | 8,537,937 |
| 2021-03-04 | 11.71 | 10.92 | 12.01 | 10.7801 | 8,166,942 |
| 2021-03-03 | 11.7 | 11.87 | 12.15 | 11.55 | 5,114,012 |
| 2021-03-02 | 11.81 | 11.74 | 12.2021 | 11.68 | 4,481,165 |
| 2021-03-01 | 11.27 | 11.98 | 12.08 | 11.2 | 5,731,971 |
| 2021-02-26 | 10.88 | 10.78 | 11.09 | 10.29 | 4,896,033 |
| 2021-02-25 | 11.09 | 10.47 | 11.64 | 10.3734 | 7,786,116 |
| 2021-02-24 | 11.17 | 11.81 | 11.85 | 10.82 | 4,736,981 |
| 2021-02-23 | 10.51 | 11.09 | 11.29 | 10.29 | 7,441,609 |
| 2021-02-22 | 11.69 | 11.19 | 12.41 | 11.06 | 8,311,660 |
| 2021-02-19 | 11 | 11.53 | 11.61 | 10.88 | 6,267,909 |
| 2021-02-18 | 10.45 | 10.8 | 10.9584 | 10.26 | 6,010,690 |
| 2021-02-17 | 10.2012 | 10.66 | 10.88 | 9.9501 | 5,890,033 |
| 2021-02-16 | 9.7 | 10.34 | 10.47 | 9.53 | 7,201,522 |
| 2021-02-15 | 9.1 | 9.57 | 9.76 | 8.86 | 8,617,509 |
| 2021-02-12 | 9.1 | 9.57 | 9.76 | 8.86 | 8,584,238 |
| 2021-02-11 | 9.6 | 9.2 | 9.73 | 9.17 | 5,824,112 |
| 2021-02-10 | 9.86 | 9.55 | 10.07 | 9.4 | 5,164,332 |
| 2021-02-09 | 10.25 | 9.9 | 10.2554 | 9.82 | 5,324,941 |
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
RESEARCH TRIANGLE PARK, N.C., March 02, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has submitted a marketing authorization application (MAA) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (M...
-
For investors and media only RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has ad...
-
BioCryst Pharmaceuticals (NASDAQ: BCRX) stock is dropping sharply on Thursday after the biotech company reported disappointing fourth-quarter financial results. BioCryst's shares were down by 8.4% as of 1:53 p.m. EST. BioCryst's total revenue for the fourth quarter ending Dec. 3...